drugset / Trial / NCT00816244

Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

NCT00816244

Phase 2 Completed 50 enrolled Lund University Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to monitor: * Tumor biological alterations following two weeks of neo-adjuvant statin therapy. * Effects of statins on tumor proliferation. * Functional studies on the mevalonate pathway.

Timeline

Start
2009-01
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg

Indications